The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons - PubMed (original) (raw)

The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons

Pim Cuijpers et al. World Psychiatry. 2013 Jun.

Abstract

Although psychotherapy and antidepressant medication are efficacious in the treatment of depressive and anxiety disorders, it is not known whether they are equally efficacious for all types of disorders, and whether all types of psychotherapy and antidepressants are equally efficacious for each disorder. We conducted a meta-analysis of studies in which psychotherapy and antidepressant medication were directly compared in the treatment of depressive and anxiety disorders. Systematic searches in bibliographical databases resulted in 67 randomized trials, including 5,993 patients that met inclusion criteria, 40 studies focusing on depressive disorders and 27 focusing on anxiety disorders. The overall effect size indicating the difference between psychotherapy and pharmacotherapy after treatment in all disorders was g=0.02 (95% CI: -0.07 to 0.10), which was not statistically significant. Pharmacotherapy was significantly more efficacious than psychotherapy in dysthymia (g=0.30), and psychotherapy was significantly more efficacious than pharmacotherapy in obsessive-compulsive disorder (g=0.64). Furthermore, pharmacotherapy was significantly more efficacious than non-directive counseling (g=0.33), and psychotherapy was significantly more efficacious than pharmacotherapy with tricyclic antidepressants (g=0.21). These results remained significant when we controlled for other characteristics of the studies in multivariate meta-regression analysis, except for the differential effects in dysthymia, which were no longer statistically significant.

PubMed Disclaimer

Figures

Figure 1

Selection and inclusion of studies

Figure 2

Differential effects of psychotherapy and pharmacotherapy (Hedges' g)

Cited by

Mediators and theories of change in psychotherapy with adolescents: a systematic review protocol.
Taubner S, Saliba A, Heinonen E, Protić S, Volkert J, Adler A, Barkauskiene R, Conejo Cerón S, Di Giacomo D, Ioannou Y, Mestre JM, Moreno-Peral P, Mucha Vieira F, Mota CP, Raleva M, Rangel Santos Henriques MI, Røssberg JI, Schmidt SJ, Stepišnik Perdih T, Ulberg R, Sales CMD. Taubner S, et al. BMJ Open. 2021 Mar 5;11(3):e042411. doi: 10.1136/bmjopen-2020-042411. BMJ Open. 2021. PMID: 33674369 Free PMC article.
Efficacy, Safety, and Evaluation Criteria of mHealth Interventions for Depression: Systematic Review.
Duarte-Díaz A, Perestelo-Pérez L, Gelabert E, Robles N, Pérez-Navarro A, Vidal-Alaball J, Solà-Morales O, Sales Masnou A, Carrion C. Duarte-Díaz A, et al. JMIR Ment Health. 2023 Sep 27;10:e46877. doi: 10.2196/46877. JMIR Ment Health. 2023. PMID: 37756042 Free PMC article. Review.
Comparative Efficacy and Acceptability of Pharmacological, Psychotherapeutic, and Combination Treatments in Adults With Posttraumatic Stress Disorder: A Network Meta-analysis.
Merz J, Schwarzer G, Gerger H. Merz J, et al. JAMA Psychiatry. 2019 Sep 1;76(9):904-913. doi: 10.1001/jamapsychiatry.2019.0951. JAMA Psychiatry. 2019. PMID: 31188399 Free PMC article.
Efficacy and cost-effectiveness of a blended cognitive behavioral therapy for depression in Spanish primary health care: study protocol for a randomised non-inferiority trial.
Vara MD, Herrero R, Etchemendy E, Espinoza M, Baños RM, García-Palacios A, Lera G, Folch B, Palop-Larrea V, Vázquez P, Franco-Martín M, Kleiboer A, Riper H, Botella C. Vara MD, et al. BMC Psychiatry. 2018 Mar 23;18(1):74. doi: 10.1186/s12888-018-1638-6. BMC Psychiatry. 2018. PMID: 29566656 Free PMC article.
Does concurrent medication usage affect patient response to internet-delivered cognitive behaviour therapy for depression and anxiety?
Edmonds M, McCall H, Dear BF, Titov N, Hadjistavropoulos HD. Edmonds M, et al. Internet Interv. 2019 Dec 29;19:100302. doi: 10.1016/j.invent.2019.100302. eCollection 2020 Mar. Internet Interv. 2019. PMID: 32071886 Free PMC article.

References

1. Kessler RC, Berglund P, Demler O, et al. National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA. 2003;289:3095–105. - PubMed
1. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602. - PubMed
1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442. - PMC - PubMed
1. Berto P, D'Ilario D, Ruffo P, et al. Depression: cost-of-illness studies in the international literature: a review. J Ment Health Policy Econ. 2000;3:3–10. - PubMed
1. Greenberg PE, Birnbaum HG. The economic burden of depression in the US: societal and patient perspectives. Exp Opin Pharmacother. 2005;6:369–76. - PubMed

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal

The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons - PubMed (original) (raw)